−7.32
Monopar Therapeutics
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−7.23
FY23:
−7.86
FY24:
−6.40
FY25:
−12.2
millions USD
FY21:
0
FY22:
−4.92
FY23:
4.93
FY24:
−14.3
FY25:
−63.5
Change from FY21 to FY25
millions USD
FY21:
10.9
FY22:
0.03
FY23:
2.03
FY24:
59.3
FY25:
91.6
millions USD
FY21:
3.57
FY22:
−12.1
FY23:
−0.92
FY24:
38.6
FY25:
16.0
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
−7.86
FY24:
–
FY25:
–
All amounts in millions USD